Skip to main content

Boyle Scott N's Form 4 filing

C4 Therapeutics, Inc. (CCCC) · filed Feb 18, 2025

Accession no.
0001662579-25-000019
Filed
Feb 18, 2025
Trade date
Feb 13-18, 2025
Filing delay
5 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.65K. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Boyle Scott NCIK 0001913897Officer (Chief Business Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 13, 2025Common StockFTax withholdingDisposed−1,735$3.20−$5,55254,832Direct
Feb 14, 2025Common StockAGrant or awardAcquired+56,500$0.00$0111,332Direct
Feb 14, 2025Common StockSSaleDisposed−490$3.15−$1,543.5110,842Direct
Feb 14, 2025Common StockFTax withholdingDisposed−2,368$3.18−$7,530.24108,474Direct
Feb 18, 2025Common StockSSaleDisposed−669$3.15−$2,107.35107,805Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 14, 2025Common StockAGrant or awardAcquired+84,700$0.00$084,700Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)